July 19-21 2016 | Boston

  • Uncover emerging next generation models that will enhance preclinical strategies

As the critical bedrock for the successful development of more effective and personalised cancer therapies, the 4th Annual Tumor Models Boston Summit is back with even more preclinical and clinical case studies to help you enhance your preclinical predictability studies, biomarker validation and translational decision making to achieve rapid clinical and regulatory success.

Discover how to advance your latest candidates into a human clinical setting in full confidence and reduce the chance of clinical failure. At the Tumor Models Summit 2016, witness large pharma, biotech and leading academia demonstrate how to apply more predictable oncology models to improve key study design elements, such as patient stratification, and highlight novel in vitro, ex vivo, in vivo & in silico modelling techniques that are laying the foundations of clinical success. [Read more…]

"Excellent Tumor Models meeting that was very well attended. Great program, speakers and panelists, which made for productive discussions, networking and exchange of ideas."

- Genentech

Join Us on Linkedin 3